MedPath
NMPA Approval

Amivantamab Injection

国药准字SJ20250005

February 8, 2025

Drug Information

埃万妥单抗注射液

锐珂

注射剂

350mg(7.0ml)/瓶

生物制品

February 8, 2025

February 7, 2030

Company Information

Applicant Company

Turnhoutseweg 30, B-2340 Beerse, Belgium

Manufacturing Company

Cilag AG

Hochstrasse 201, 8200 Schaffhausen, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

埃万妥单抗注射液 - NMPA 批准文号 | MedPath